Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 193.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000007 (1999)	A. Samii [Canada] ; I M Turnbull ; A. Kishore ; M. Schulzer ; E. Mak ; S. Yardley ; D B Calne	Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.
000026 (1999)	D B Calne [Canada]	Differentiation of dopamine agonists and their role in the treatment of Parkinson's disease.
000044 (1999)	P J Blanchet [Canada]	Rationale for use of dopamine agonists in Parkinson's disease: review of ergot derivatives.
000045 (1999)	D E Hobson [Canada] ; E. Pourcher ; W R Martin	Ropinirole and pramipexole, the new agonists.
000047 (1999)	D A Grimes [Canada] ; A E Lang	Treatment of early Parkinson's disease.
000074 (2000)	R. Grondin [Canada] ; A. Hadj Tahar ; V D Doan ; P. Ladure ; P J Bédard	Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys.
000107 (????)	D J Chong [Canada] ; O. Suchowersky ; C. Szumlanski ; R M Weinshilboum ; R. Brant ; N R Campbell	The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.
000123 (????)	A. Hadj Tahar [Canada] ; L. Grégoire ; E. Bangassoro ; P J Bédard	Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys.
000125 (2000)		Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
000156 (2001)	H. Moller	Antiparkinsonian drugs and "sleep attacks".
000174 (2001)	A H Rajput [Canada]	Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
000175 (2001)	R. De La Fuente-Fernández [Canada] ; T J Ruth ; V. Sossi ; M. Schulzer ; D B Calne ; A J Stoessl	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
000183 (2001)	A H Rajput [Canada]	The protective role of levodopa in the human substantia nigra.
000190 (2001)	R. De La Fuente-Fernández [Canada] ; A S Lim ; V. Sossi ; J E Holden ; D B Calne ; T J Ruth ; A J Stoessl	Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
000191 (2001)	M. Etminan [Canada] ; A. Samii ; B. Takkouche ; P A Rochon	Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
000202 (2002)	Quincy J. Almeida [Canada] ; Laurie R. Wishart ; Timothy D. Lee	Bimanual coordination deficits with Parkinson's disease: the influence of movement speed and external cueing.
000203 (2002)	Frédéric Calon [Canada] ; Sam Birdi ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo	Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
000206 (2000)	L. Mcauley	Entacapone: adjunctive use in patients with advanced Parkinson's disease.
000208 (2002)	Azi H. Rajput [Canada] ; Mark E. Fenton ; Sam Birdi ; Rob Macaulay ; David George ; Bohdar Rozdilsky ; Lee C. Ang ; Ambikaipakan Senthilselvan ; Oleh Hornykiewicz	Clinical-pathological study of levodopa complications.
000211 (2002)		Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
000219 (2002)	J F Gagnon [Canada] ; J. Montplaisir ; M A Bédard	[Rapid-eye-movement sleep disorders in Parkinson's disease].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022